© 2022 MJH Life Sciences and Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
May 01, 2017
Major changes may be coming for the prevention of persistent migraines.
April 27, 2017
Brivaracetam was approved because it was effective reducing seizure frequency when combined with other agents.
April 26, 2017
Monoclonal antibody drugs may soon be an effective preventative treatment for chronic migraines.
Erenumab is a monoclonal antibody that inhibits a neuropeptide strongly believed to play a role in the pathology of migraines.
April 25, 2017
Atrial fibrillation is also more commonly the etiology behind stroke in women than in men.
April 24, 2017
Amgen is claiming patent infringement against Sanofi and Regeneron based on the biological mechanisms of dupilumab (Dupixent).